(Q42981018)

12 November 2017

title

Effect of obesity on pharmacokinetics and biologic effect of interferon-alpha in hepatitis C. (English)

1 reference

12 November 2017

1 reference

N P Lam

1

1 reference

12 November 2017

D Pitrak

2

1 reference

12 November 2017

R Speralakis

3

1 reference

12 November 2017

A H Lau

4

1 reference

12 November 2017

T E Wiley

5

1 reference

12 November 2017

T J Layden

6

1 reference

12 November 2017

publication date

1 January 1997

1 reference

Digestive Diseases and Sciences

12 November 2017

published in

1 reference

12 November 2017

volume

42

1 reference

12 November 2017

issue

1

1 reference

12 November 2017

page(s)

178-185

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1018865928308

12 November 2017

exact match

0 references

cites work

Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus

1 reference

12 December 2020

Phenobarbital pharmacokinetics in obesity. A case report

1 reference

12 December 2020

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

1 reference

12 December 2020

Correlation between insulin receptor binding in isolated fat cells and insulin sensitivity in obese human subjects

1 reference

12 December 2020

1 reference

12 December 2020

Long-term follow-up of patients with chronic hepatitis C treated with α-interferon

1 reference

12 December 2020

Relationship between in Vivo Insulin Resistance and Decreased Insulin Receptors in Obese Man*

1 reference

12 December 2020

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Prolongation of ifosfamide elimination half-life in obese patients due to altered drug distribution

1 reference

12 December 2020

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

1 reference

12 December 2020

Fat body mass and pharmacokinetics of oral 6-mercaptopurine in children with acute lymphoblastic leukemia

1 reference

12 December 2020

Drug disposition in obese humans. An update

1 reference

12 December 2020

Interferon-associated lymphocyte 2',5'-oligoadenylate synthetase in acute and chronic viral hepatitis

1 reference

12 December 2020

Measurement of 2',5'-oligoadenylate synthetase in patients receiving interferon-alpha

1 reference

12 December 2020

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

12 December 2020

In vitro insensitivity of glucose transport and antilipolysis to insulin due to receptor and postreceptor abnormalities in obese Pima Indians with normal glucose tolerance

1 reference

12 December 2020

Prediction of the response of chronic hepatitis C to interferon alfa: a statistical analysis of pretreatment variables.

1 reference

12 December 2020

Factors predictive of the response to interferon in patients with chronic hepatitis C

1 reference

12 December 2020

Influence of weight on aminoglycoside pharmacokinetics in normal weight and morbidly obese patients

1 reference

12 December 2020

Factors predicting early response to treatment with recombinant interferon alpha-2a in chronic non-A, non-B hepatitis. Preliminary report of a long-term trial

1 reference

12 December 2020

Comparative pharmacokinetics of intravenous propranolol in obese and normal volunteers

1 reference

12 December 2020

The Glucose Uptake of Human Adipose Tissue in Obesity

1 reference

12 December 2020

Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects

1 reference

12 December 2020

Clinical and histologic predictors of response to interferon-alpha in patients with chronic hepatitis C viral infection

1 reference

12 December 2020

Assay of an interferon-induced enzyme in white blood cells as a diagnostic aid in viral diseases

1 reference

12 December 2020

Interferon alfa treatment of chronic hepatitis B: Randomized trial in a predominantly homosexual male population

1 reference

12 December 2020

The interferons. Mechanisms of action and clinical applications

1 reference

12 December 2020

Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy

1 reference

12 December 2020

Biologic response (antiviral) to recombinant human interferon alpha 2a as a function of dose and route of administration in healthy volunteers.

1 reference

12 December 2020

Cimetidine clearance in the obese

1 reference

12 December 2020

Use of aminotransferase, hepatitis C antibody, and hepatitis C polymerase chain reaction RNA assays to establish the diagnosis of hepatitis C virus infection in a diagnostic virology laboratory

1 reference

12 December 2020

Monitoring of Interferon Therapy by Assay of (2′-5′) Oligo-Isoadenylate Synthetase in Human Peripheral White Blood Cells

1 reference

12 December 2020

Mechanisms of action of interferons

1 reference

12 December 2020

Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources

1 reference

12 December 2020

Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection

1 reference

12 December 2020

The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1018865928308

1 reference

Dimensions Publication ID

12 November 2017

1001448144

0 references

1 reference